- Home
- RAYA vs ANEB Comparison
RAYA vs ANEB Comparison
Compare RAYA & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- ANEB
- Stock Information
- Founded
- RAYA 2019
- ANEB 2020
- Country
- RAYA China
- ANEB United States
- Employees
- RAYA N/A
- ANEB N/A
- Industry
- RAYA Metal Fabrications
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- RAYA Consumer Discretionary
- ANEB Health Care
- Exchange
- RAYA Nasdaq
- ANEB Nasdaq
- Market Cap
- RAYA 35.8M
- ANEB 36.7M
- IPO Year
- RAYA 2022
- ANEB 2021
- Fundamental
- Price
- RAYA $1.26
- ANEB $1.54
- Analyst Decision
- RAYA
- ANEB Buy
- Analyst Count
- RAYA 0
- ANEB 1
- Target Price
- RAYA N/A
- ANEB $8.00
- AVG Volume (30 Days)
- RAYA 9.3K
- ANEB 13.3K
- Earning Date
- RAYA 01-01-0001
- ANEB 02-11-2025
- Dividend Yield
- RAYA N/A
- ANEB N/A
- EPS Growth
- RAYA N/A
- ANEB N/A
- EPS
- RAYA N/A
- ANEB N/A
- Revenue
- RAYA $22,816,585.00
- ANEB N/A
- Revenue This Year
- RAYA $64.53
- ANEB N/A
- Revenue Next Year
- RAYA $9.61
- ANEB N/A
- P/E Ratio
- RAYA N/A
- ANEB N/A
- Revenue Growth
- RAYA N/A
- ANEB N/A
- 52 Week Low
- RAYA $0.50
- ANEB $0.80
- 52 Week High
- RAYA $1.78
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- RAYA 47.39
- ANEB 48.92
- Support Level
- RAYA $1.21
- ANEB $1.45
- Resistance Level
- RAYA $1.44
- ANEB $1.75
- Average True Range (ATR)
- RAYA 0.09
- ANEB 0.14
- MACD
- RAYA -0.00
- ANEB -0.01
- Stochastic Oscillator
- RAYA 37.93
- ANEB 41.78
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from three products namely inverters, chargers, and gasoline generators. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.